| 摘要 |
This invention relates to methods, pharmaceutical compositions and kits useful in treating cataracts. The compositions are comprised of an estrogen agonist / antagonist and a pharmaceutically acceptable vehicle, carrier or diluent. The compositions and methods of treatment are effective while substantially reducing the concomitant liability of adverse effects associated with estrogen administration. |
